Legend Biotech LEGN Income Statement (2019-2026)

NASDAQ LEGN
$21.59 -0.16 (-0.74%)
As of: Sep 4, 2026 · 3:40 PM EDT
Reported Financials

Legend Biotech Quarterly Income Statement

Periods 29 quarters
Latest Jun 2026

Legend Biotech reported revenue of $387.50M and net income of $33.20M for the quarter ended Jun 2026, up 51.9% year over year. This income statement covers 29 quarters of results from Jun 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue
16.88M38.99M50.04M11.97M27.36M27.63M36.34M73.33M96.01M79.46M93.99M186.52M160.21M186.50M195.00M255.10M272.33M306.30M305.10M387.50M
Cost of RevenueCost of Rev
25.46M22.96M35.61M32.67M43.48M32.45M49.10M45.35M52.51M4.40M1.00M94.90M113.26M-276.63M3.20M136.00M
Gross Profit
1.90M4.67M0.72M40.66M52.53M47.01M44.89M141.17M107.69M182.10M194.00M160.20M159.07M582.93M301.90M251.50M
Operating items
Research & DevelopmentR&D
-72.31M-86.50M-81.55M-68.83M-104.52M-80.76M-84.89M-95.79M-95.86M-105.68M-100.96M-112.63M-95.52M-104.40M-101.90M-98.30M-113.15M-101.30M-85.70M-96.00M
Selling, General & AdministrativeSG&A
-11.81M-17.14M-12.66M-18.05M-23.24M-26.68M-22.20M-27.75M-28.10M-28.71M-31.93M-35.35M-35.30M-34.20M-31.50M-32.60M-34.72M-37.00M-40.00M-33.00M
Other Operating ExpensesOther Opex
0.04M-4.42M-0.97M
Operating ExpensesOpex
-84.12M-103.64M-94.20M-86.88M-127.76M-107.44M-107.09M-123.54M-123.96M-134.39M-132.89M-147.98M-130.82M-138.60M-133.40M-130.90M-147.87M-138.30M-125.70M-129.00M
Operating IncomeOp. Inc
129.66M112.11M107.82M164.20M176.49M181.40M177.78M289.15M-70.36M-79.30M-51.70M-21.90M-43.45M-19.70M-49.80M57.70M
EBIT
-124.96M-407.80M-33.17M-194.71M129.66M112.11M107.82M164.20M176.49M181.40M177.78M289.15M-70.36M-79.30M-51.70M-21.90M-43.45M-19.70M-49.80M57.70M
Non-operating items
Non Operating Interest Expenses
-0.21M-0.60M-1.04M-1.64M-3.25M-4.86M-5.11M-5.18M-5.68M-5.82M-5.47M-5.48M-5.50M-5.20M-5.10M-5.20M-5.64M-5.50M-5.50M-5.80M
Interest & Investment IncomeInt & Inv Inc
13.87M17.05M16.63M13.70M12.10M10.40M9.66M7.90M7.30M5.60M
Other Non Operating IncomeOther Non Op Inc.
-35.80M31.20M34.90M-65.90M61.20M-9.30M20.00M-105.75M113.95M49.68M12.44M-61.66M-109.76M55.20M-108.10M0.35M-2.40M5.90M-2.00M
Net income details
EBT
-124.75M-407.20M-32.13M-193.07M-84.80M-135.72M-111.97M-198.84M-62.49M-146.81M-59.79M-17.97M-120.89M40.60M-99.20M-124.80M-39.07M-19.70M-53.10M55.50M
Tax ProvisionsTaxes
3.62M-0.16M-0.16M-0.15M-0.15M-0.13M-0.29M0.29M1.99M-0.01M-0.23M-4.43M-14.20M-1.80M-0.60M-0.62M-11.20M-1.20M-22.30M
Profit After TaxPAT
-124.75M-88.33M-32.29M-193.23M-84.96M-135.88M-112.10M-199.13M-62.21M-144.82M-59.79M-18.20M-125.32M-59.00M-101.00M-125.40M-39.69M-30.90M-54.30M33.20M
Income from Continuing OperationsIncome (Continuing)
-124.75M-410.81M-31.96M-192.91M-84.65M-135.57M-111.84M-198.55M-62.78M-148.81M-59.78M-17.74M-116.45M54.80M-97.40M-124.20M-38.46M-8.50M-51.90M77.80M
Consolidated Net IncomeConsol Net Inc.
-124.75M-410.81M-31.96M-192.91M-84.65M-135.57M-111.84M-198.55M-62.78M-148.81M-59.78M-17.74M-116.45M54.80M-97.40M-124.20M-38.46M-8.50M-51.90M77.80M
Income towards Parent CompanyParent Net Inc
-124.75M-88.33M-32.29M-193.23M-84.96M-135.88M-112.10M-199.13M-62.21M-144.82M-59.79M-199.13M-125.32M26.28M-100.92M-124.20M-38.46M-8.50M-51.90M77.80M
Net Income towards Common StockholdersNet Income
2.82M-88.33M-32.29M-193.23M-84.96M-135.88M13.51M-6.97M-20.24M-88.55M-47.99M-10.54M61.90M-59.08M60.73M-124.20M-38.46M-8.50M-51.90M77.80M
Additional items
EPS (Basic)
0.02-0.63-0.23-1.37-0.60-0.850.08-0.04-0.13-0.50-0.27-0.060.35-0.320.33-0.68-0.21-0.05-0.280.42
EPS (Diluted)
-0.850.08-0.04-0.13-0.50-0.27-0.060.35-0.320.33-0.68-0.21-0.05-0.280.42
Shares Outstanding
118.15M140.85M140.85M140.85M140.85M159.04M159.04M159.04M159.04M176.08M176.08M176.08M176.08M182.85M182.85M182.85M182.85M184.32M184.32M184.32M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
159.04M159.04M159.04M159.04M176.08M176.08M176.08M176.08M182.85M182.85M182.85M182.85M184.32M184.32M184.32M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
154.23M165.07M181.91M183.65M184.32M
EBITDA
-124.96M-407.80M-33.17M-194.71M129.66M112.11M107.82M164.20M176.49M181.40M177.78M289.15M-70.36M-79.30M-51.70M-21.90M-43.45M-19.70M-49.80M57.70M
Interest ExpensesInt Expense
-0.21M-0.60M-1.04M-1.64M-3.25M-4.86M-5.11M-5.18M-5.68M-5.82M-5.47M-5.48M-5.50M-5.20M-5.10M-5.20M-5.64M-5.50M-5.50M-5.80M
Tax Rate
-0.89%0.51%0.08%0.18%0.11%0.11%0.15%-0.46%-1.36%0.01%1.26%3.67%-34.98%1.81%0.48%1.58%56.85%2.26%-40.18%